This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1538574408320172v1 42/4/305    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Google Scholar Articles by Maier, K. G. PubMed PubMed Citation Articles by Maier, K. G. Social Bookmarking                   What's this?

Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Diabetes: Vascular Implications

^* To whom correspondence should be addressed. E-mail: maierk{at}upstate.edu.

	Abstract

Vascular disease associated with diabetes mellitus is a major cause of morbidity and mortality and is increasing in the United States. It is now recognized that oxidative stress plays a substantial role in the underlying vascular pathology of several diseases, including hypertension and diabetes. In diabetes, there is an increase in the steady state levels of reactive oxygen species. One of the primary generators of reactive oxygen species is nicotinamide adenine dinucleotide phosphate oxidase. Studies have indicated that inhibition of this system is associated with vascular benefits in diabetes. Therefore, there may be a role for therapies directed at nicotinamide adenine dinucleotide phosphate oxidase in this disease. This review will examine the structure, activation, potential role in vascular disease, and benefits of inhibition of nicotinamide adenine dinucleotide phosphate oxidase.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?